WeChat Mini Program
Old Version Features

A Multicenter Prospective Study of TACE Combined with Lenvatinib and Camrelizumab for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

CANCER MEDICINE(2023)

Cited 5|Views17
Key words
camrelizumab,hepatocellular carcinoma,lenvatinib,portal vein tumor thrombus,transarterial chemoembolization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined